Kristine Geldnere

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients

Linda Tarāsova, Ineta Kalniņa, Kristine Geldnere et al. · Pharmacogenetics and Genomics · 2012 · 131 citations

Skin Complications of Diabetes Mellitus Revealed by Polarized Hyperspectral Imaging and Machine Learning

Viktor Dremin, Zbigņevs Marcinkevičs, Evgeny Zherebtsov et al. · IEEE Transactions on Medical Imaging · 2021 · 128 citations · Full text

Engineering, Machine Learning, Disease Detection +17

Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients

Linda Zaharenko, Ineta Kalniņa, Kristine Geldnere et al. · European Journal of Endocrinology · 2016 · 29 citations · Full text